Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
The First Hospital of Jilin University
The First Hospital of Jilin University
Rutgers, The State University of New Jersey
Dublin City University
Hospices Civils de Lyon
University Health Network, Toronto
University Hospital, Ghent
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
University of Santo Tomas Hospital, Philippines
University of British Columbia
Assistance Publique - Hôpitaux de Paris
Sahlgrenska University Hospital
Alanya Alaaddin Keykubat University
WomenX Biotech Limited
WomenX Biotech Limited
Kaiser Permanente
Universitätsklinikum Hamburg-Eppendorf
University of Southern Denmark
Chinese University of Hong Kong
Institute of Oncology Ljubljana
Zonguldak Bulent Ecevit University
The Greater Poland Cancer Centre
University of Utah
University of Arizona
Sciensano
Jules Bordet Institute
Precision Robotics (Hong Kong) Limited
Royal Surrey County Hospital NHS Foundation Trust
University Ghent
National Institute of Cancerología
National Institute of Cancerología
National Institute of Cancerología
Peking University People's Hospital
Lund University
Massachusetts General Hospital
Qilu Hospital of Shandong University
Chongqing University Cancer Hospital
Loyola University
Royal Marsden NHS Foundation Trust
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Precision Robotics (Hong Kong) Limited
The Affiliated Hospital of Qingdao University
Peking Union Medical College Hospital
Peking University People's Hospital
Ankara Yildirim Beyazıt University
Cambridge University Hospitals NHS Foundation Trust
Ruijin Hospital
University of California, Los Angeles
The First Affiliated Hospital of Xiamen University
Ruijin Hospital